Advice for Clinicians on JAK Inhibitors

January 26, 2022

Linda Stein Gold, MD, and Matthew Zirwas, MD, share some advice for clinicians on how to discuss JAK inhibitors with patients.

Solve the Challenges of Mild to Moderate Psoriasis
AK, SCC Treatments Focus on Efficacy, Tolerability, Durability
Hyperpigmentation Treatment Toolbox
New Indications, Mechanisms Drive Second-Line Treatments